Don’t let allergies put young patients’ lives on hold!
Don’t let allergies put young patients’ lives on hold!
Piri, the UK’s No 1 selling allergy range1 has announced that Piriteze Allergy Relief Syrup is now available from pharmacies, suitable from 2+ years.
Did you know, hayfever and allergic rhinitis affects up to 40% of children and is the most common chronic disease in childhood?2,3 Additionally, incidence of food allergy tends to be greater in young children and toddlers (almost 1 in 12).4 Pet allergies may also cause a range of symptoms and are much more likely if patients have allergic asthma or hayfever.5 Allergy symptoms may mean that children don’t get to enjoy outdoor fun with family and can even impact sleep patterns.6
Piriteze Allergy Relief Syrup is now available in pharmacy and can be recommended to children from 2+ years to relieve a range of allergy symptoms including:
- Nasal symptoms such as runny or itchy nose
- Itchy, watery eyes
- Itchy rash such as hives
Piriteze Allergy Relief Syrup offers convenient dosing and comes in a sugar-free banana flavour.
Find out more about the Piri range and access pharmacy resources related to managing allergy symptoms at www.gskhealthpartner.com.
- Nielsen Scantrack Data. Total Coverage GB, unit sales L12W w/e 4.12.21
- Turner PJ and Kemp A S. Allergic rhinitis in children. J Paediatr Child Health. 2012; 48(4): 302-10. Available at https://onlinelibrary.wiley.com/doi/10.1111/j.1440-1754.2010.01779.x
- Skadding GK. Optimal management of allergic rhinitis. Arch Dis Child 2015; 100: 576-582
- Types of allergies. Available at: https://www.allergyuk.org/types-of-allergies/
- Quick guide to pet/animal allergy. Allergy UK. Available at https://www.allergyuk.org/wp-content/uploads/2021/10/Pet-Allergy.pdf
- Allergy in childhood. Allergy UK. https://www.allergyuk.org/about-allergy/allergy-in-childhood/
Visit https://www.medicines.org.uk/emc/product/13429 for Product Information. Piriteze Allergy Relief Syrup 70ml: £4.87 (excl. VAT).
Trade marks are owned by or licensed to the GSK group of companies.
PM-UK-PIRI-22-00113